Predict your next investment

Celsius Therapeutics company logo
HEALTHCARE | Biotechnology
celsiustx.com

See what CB Insights has to offer

Founded Year

2017

Stage

Series A | Alive

Total Raised

$65M

Last Raised

$65M | 3 yrs ago

About Celsius Therapeutics

Celsius Therapeutics is applying a systematic approach to single-cell sequencing, combining massive datasets and complex algorithms in order to discover precision therapies that havean impact on the lives of patients with autoimmune diseases and cancer. By analyzing single cells, Celsius' approach has the potential to understand the causes of disease at an entirely new level of resolution that overcomes limitations of traditional genomic sequencing approaches.

Celsius Therapeutics Headquarter Location

399 Binney Street

Cambridge, Massachusetts, 02139,

United States

857-776-7400

Latest Celsius Therapeutics News

Global Single Cell Genomics Market Forecasts 2021-2025 by End-user & Technology with Executive & Consultant Guides, Including Customized Forecasting and Analysis with COVID-19 Updates - ResearchAndMarkets.com

Apr 9, 2021

Search jobs 09-Apr-2021 Global Single Cell Genomics Market Forecasts 2021-2025 by End-user & Technology with Executive & Consultant Guides, Including Customized Forecasting and Analysis with COVID-19 Updates - ResearchAndMarkets.com Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures. There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology. This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. Key Topics Covered: 1.1 What is Single Cell Genomics? 1.2 SCG - Still Early Days 1.3 Market Definition 1.5.1 Cost, Price and Genome Size, Pricing Practice 1.6 Global Listing of High Throughput Sequencing Establishments Installed Base - Location & Contacts 2. Single Cell Genomics - Guide to Technology 2.1 Isolating Single Cells 2.2.2 WGA - Whole Genome Amplification 2.3 PCR 3. Industry Overview 3.1.1 Academic Research Lab 3.1.4 Cell Line and Reagent Supplier 3.1.5 Pharmaceutical or Reagent Company 3.1.6 Audit Body 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Parse Biosciences Lowers Cost Barriers to Single-Cell Transcriptomics Deepcell Advancing Tech for Single-Cell Genomics 10x Genomics Outlines 2021 Growth Plans Single-Cell Genomics Firm Analytical Biosciences Inks Deal with BioMap IsoPlexis Features Cheaper, More Flexible Single-Cell Proteomic Systems DNTR-Seq Combines WGS, Transcriptomics in Single Cells BitBiome Builds Single-Cell Bacterial Sequencing Business S2 Genomics Signs Distribution Agreements for Asia-Pacific Single-Cell COVID-19 Study Investigates Immune Hyperactivation Levitas Bio to Launch Magnetic Levitation Cell Separation Platform Single-Cell and Spatial Genomics Vizgen Launches With $14M Series A Financing SeqWell Raises $9M in Series B Round MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology 10x Genomics Expects $271M In Proceeds Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts Bio-Rad Launches its Single Cell scATAC-Seq Solution 10x Genomics Acquires Spatial Transcriptomics Takara Bio strengthens its IP position on single cell RNA-seq Mission Bio Launches Tapestri for Targeted Single-Cell DNA Custom Panels SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells 1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine Sony MA900 Cell Sorter Nominated UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV Diagnostic Assay IncellDx's Single Cell Immuno-Oncology/PD-L1 Technology used in new Cancer Assay Cytena GmbH land EUR 3M in Series A NanoString Announces Launch of CAR-T Panel Dolomite Bio launches high throughput single nuclei profiling on Nadia platform Silicon Biosystems Develops New Assay for Circulating Multiple Myeloma Cells 6. Profiles of Key Single Cell Genomics Companies 10x Genomics 7.1 Global Market Overview by Country 7.2 Global Market Size by Technology - Overview 7.3 Global Market End-user - Overview 8. Global Market by Technology 8.1 PCR Market 9.1 Research Market 10.2 Clinical Trials Started 2010 to 2016 10.3 Prevalence of Cancer Treatments For more information about this report visit https://www.researchandmarkets.com/r/kqnifz Contacts For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Editor Details PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.4.7.1 You are leaving PharmiWeb.com Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com. PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Celsius Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Celsius Therapeutics is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

A

Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.

A

Artificial Intelligence

7,340 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Celsius Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Celsius Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.